8X2O

RIPK2 in complex with K252

Summary for 8X2O

• Entry DOI: 10.2210/pdb8x2o/pdb
• Descriptor: Receptor-interacting serine/threonine-protein kinase 2, ~{N}-[(1~{R})-4-[4-[(6-fluoranyl-1,3-benzothiazol-5-yl)amino]thieno[2,3-d]pyrimidin-6-yl]cyclohex-3-en-1-yl]cyclopropanecarboxamide (3 entities in total)
• Functional Keywords: inhibitor, immune system
• Biological source: Homo sapiens (human)
• Total number of polymer chains: 2
• Total formula weight: 73558.63

Authors

Yang, J.H.,Yang, J.H. (deposition date: 2023-11-10, release date: 2024-11-13, Last modification date: 2025-05-28)

• Primary citation: Chen, Y.,Yuan, X.,Yan, W.,Zou, Y.,Wei, H.,Wei, Y.,Tang, M.,Chen, Y.,Ma, Z.,Yang, T.,Liu, K.,Xiong, B.,Hu, X.,Yang, J.,Chen, L.; CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury; Acta Pharm Sin B, 2025; DOI: 10.1016/j.apsb.2025.05.003

Experimental method

X-RAY DIFFRACTION (2.26 Å)